We serve Chemical Name:HYDROPRENE CAS:41096-46-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:HYDROPRENE
CAS.NO:41096-46-2
Synonyms:ethyl (E,E)-(RS)-3,7,11-trimethyldodeca-2,4-dienoate;altozar;gencor;rac-ethyl (2E,4E,7R)-3,7,11-trimethyldodeca-2,4-dienoate;oms1696;ethyl (2E,4E)-3,7,11-trimethyl-2,4-dodecadienoate;ethyl3,7,11-trimethyldodeca-2,4-dienoate;ethyl3,7,11-trimethyl-2,4-dodecadienoate;Hydroprene=Altozar=Encotone=Gencor;HYDROPRENE;Altozar IGR;zr512
Molecular Formula:C17H30O2
Molecular Weight:266.41900
HS Code:2916190090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:339.2ºC at 760 mmHg
Density:0.886g/cm3
Index of Refraction:1.461
PSA:26.30000
Exact Mass:266.22500
LogP:4.90450
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like ethyl (E,E)-(RS)-3,7,11-trimethyldodeca-2,4-dienoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,zr512 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl3,7,11-trimethyldodeca-2,4-dienoate Use and application,ethyl3,7,11-trimethyldodeca-2,4-dienoate technical grade,usp/ep/jp grade.
Related News: For category of products which involve fermentation technologies, incentive is 20 per cent of the approved sales price. The government has put a cap of Rs. 10 crore per product per annum for five years. This is a seven year scheme from 2023-24 going up to 2029-30. tert-butyl [4′-(2,4-dioxothiazolidin-5-ylmethyl)-2′-methylbiphenyl-3-ylmethyl]-N-methylcarbamate manufacturers The study also found that the inhaled version of the vaccine did not cause serious side effects, demonstrating an encouraging safety profile in the early-stage trial. (S)-1-((9H-carbazol-4-yl)oxy)-3-(((1-pentylpiperidin-4-yl)methyl)amino)propan-2-ol suppliers The outlay will be used to grow Takeda’s portfolio of treatments and boost capacity to manufacture additional products for the rare disease community, Stephen Hatke, Takeda’s Thousand Oaks site head, said in a YouTube video about the expansion. The company didn’t name the specific products it plans to make there. N-{3-[(N,N-dimethylaminophenyl)-4′-diazenyl]benzoyl}leucine methyl ester vendor & factory.
